CD8A and myeloid sarcoma: Taking into account that MS patients contain modestly higher frequencies of CD3+CD20+ cells, which are predominantly CD8+ T cells, it is important to invest more research in this specific subtype in order to study their potential role in the pathogenesis of MS.